ATF3 and cancer: To examine whether TChal modified the expression of HSP40 and ATF3 in other cancer cells, HCT-116 (colorectal cancer), FaDu (oral cancer), and SJSA1 (osteosarcoma) cells were treated with TChal at 50 μM for 24 h.